These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Regulation of oxidative metabolism by interferon-gamma during human monocyte to macrophage differentiation. Karhumäki E, Helin H. Med Biol; 1987; 65(5-6):261-6. PubMed ID: 2836672 [Abstract] [Full Text] [Related]
28. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes. Utsugi T, Sone S. J Immunol; 1986 Feb 01; 136(3):1117-22. PubMed ID: 3079797 [Abstract] [Full Text] [Related]
29. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. Sampson-Johannes A, Carlino JA. J Immunol; 1988 Nov 15; 141(10):3680-6. PubMed ID: 3053901 [Abstract] [Full Text] [Related]
30. Interaction between human peripheral blood monocytes and tumor promoters: effect on growth differentiation and function in vitro. Keisari Y, Bucana C, Markovich S, Campbell DE. J Biol Response Mod; 1990 Aug 15; 9(4):401-10. PubMed ID: 2118562 [Abstract] [Full Text] [Related]
31. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. Cathcart MK, McNally AK, Morel DW, Chisolm GM. J Immunol; 1989 Mar 15; 142(6):1963-9. PubMed ID: 2537865 [Abstract] [Full Text] [Related]
32. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor. Chen AR, McKinnon KP, Koren HS. J Immunol; 1985 Dec 15; 135(6):3978-87. PubMed ID: 3905966 [Abstract] [Full Text] [Related]
33. Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Mytar B, Siedlar M, Wołoszyn M, Ruggiero I, Pryjma J, Zembala M. Br J Cancer; 1999 Feb 15; 79(5-6):737-43. PubMed ID: 10070862 [Abstract] [Full Text] [Related]
34. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes. Nissen-Meyer J, Hofsli E, Espevik T, Austgulen R. Nat Immun Cell Growth Regul; 1988 Feb 15; 7(5-6):266-79. PubMed ID: 3146697 [Abstract] [Full Text] [Related]
35. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. Lee JC, Rebar L, Young P, Ruscetti FW, Hanna N, Poste G. J Immunol; 1986 Feb 15; 136(4):1322-8. PubMed ID: 3003193 [Abstract] [Full Text] [Related]
36. In vitro and in vivo effect of adriamycin therapy on monocyte activation by liposome-encapsulated immunomodulators. Hudson MM, Snyder JS, Jaffe N, Kleinerman ES. Cancer Res; 1988 Sep 15; 48(18):5256-63. PubMed ID: 3261632 [Abstract] [Full Text] [Related]
37. Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state. Sone S, Lopez-Berestein G, Fidler IJ. J Natl Cancer Inst; 1985 Mar 15; 74(3):583-90. PubMed ID: 3856062 [Abstract] [Full Text] [Related]
38. Activation of the oxidative burst in human monocytes is associated with inhibition of methionine-dependent methylation of neutral lipids and phospholipids. Bonvini E, Bougnoux P, Stevenson HC, Miller P, Hoffman T. J Clin Invest; 1984 Jun 15; 73(6):1629-37. PubMed ID: 6327766 [Abstract] [Full Text] [Related]
39. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide. Munakata T, Semba U, Shibuya Y, Kuwano K, Akagi M, Arai S. J Immunol; 1985 Apr 15; 134(4):2449-55. PubMed ID: 3919096 [Abstract] [Full Text] [Related]
40. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes. Talmadge KW, Gallati H, Sinigaglia F, Walz A, Garotta G. Eur J Immunol; 1986 Dec 15; 16(12):1471-7. PubMed ID: 3102242 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]